Monday, November 25, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Superbug News - CoronaVirus Watch List

SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the...

Editor / Curator -
American Brivision
Biotech News

Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List....

Editor / Curator -
Biotech News

Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.

Editor / Curator -
Immuron, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Immuron (IMRN) to Bank $20 Million.

Editor / Curator -
rOBINHOOD tRADER
Research

Robinhood and Robindhoodette.

Editor / Curator -
All News

And Just Like That, We Have Another Double. iBio (IBIO).

Editor / Curator -
Biotech News

Where is Citius Pharma (CTXR) in the FDA Approval Process?

Editor / Curator -
ibio
Superbug News - CoronaVirus Watch List

Adding iBIO (IBIO) $2.27 to CoronaVirus Watch List.

Editor / Curator -
video
Stand Down.

Stand Down XI. The Best Explanation of What Lies Ahead for...

Editor / Curator -
2020 Watch List

2020 Biotech Portfolio Soars 55%, We’re Amazed.

Editor / Curator -
1...646566...93Page 65 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.